Complementary Therapies of Diabetic Peripheral Neuropathy and Intermittent Claudication.
Shu Yan Ng · Healthcare (Basel, Switzerland) · 2025
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In with DPN who have limited treatment options, the combination of treatments significantly improved the patient's pain and claudication distance, increasing it from 16 m to 300-400 m. These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence sleep-related outcomes.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in with DPN who have limited treatment options. The combination of treatments significantly improved the patient's pain and claudication distance, increasing it from 16 m to 300-400 m.
What the Researchers Studied
The researchers studied with DPN who have limited treatment options.
What Effects Did Molecular Hydrogen Have?
As previously indicated, he was treated by ECP, calf-muscle electrical neuromuscular therapy, CO₂ therapy, and hydrogen therapy. The combination of treatments significantly improved the patient's pain and claudication distance, increasing it from 16 m to 300-400 m. The authors concluded that in conclusion, this case report suggests that a combination of off-label therapies may improve symptoms in patients with DPN who are refractory to standard care. Han et al. (2023) demonstrated that hydrogen administration significantly increased the density and average sectional area of myelinated nerves, which were previously broken, damaged, or missed in diabetic rats, suggesting that hydrogen may reduce nerve damage caused by hyperglycemia and oxidative stress [ 39 ]. Wang et al. (2022) demonstrated that hydrogen-rich saline alleviated the symptoms and functional impairment of neuropathic hyperalgesia in diabetic rats, with the effect correlated to a reduction in pro-inflammatory cytokine levels [ 40 ].
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence sleep-related outcomes and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a case report. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as case report with human clinical evidence. The research population or model was with DPN who have limited treatment options.
Limitations and Safety
Reported limitations: While the symptomatic results are promising, they must be interpreted with caution due to the study’s limitations, including its single-case report nature and the use of multiple simultaneous interventions.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.